Traders should view this coordinated buying by C-suite executives as a positive signal, particularly given the material dollar amount relative to typical insider activity. Monitor for follow-on purchases or commentary around upcoming earnings or clinical developments.
DCTH drugs
DCTH drug pipeline →How the stock moved after the report
BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Mar 2 $8.93entry
- T+1 · 9mo ago −3.70%α −2.78% · $8.60
- T+5 · 8mo ago +2.13%α +3.34% · $9.12
- T+20 · 8mo ago −0.45%α +7.49% · $8.89
- T+60 · 6mo ago +21.28%α +11.95% · $10.83
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Both the CEO and CFO of Delcath Systems purchased shares in the open market within the past week, collectively investing approximately $150,328. This insider buying from top executives signals confidence in the company's prospects at current valuation levels.
Key Financial Metrics
Key Facts
- CEO Michel Gerard J purchased 11,200 shares at $8.9562, spending $100,309.44
- CFO Sandra Pennell purchased 5,533 shares at $9.04, spending $50,018.32
- Total insider buying in the cluster: $150,328 over a 7-day period
- Both transactions were open-market purchases (P), indicating intentional capital deployment
- Purchases represent ~0.048% of company's $315M market cap
Financial Impact
$150,328 in insider buying over 7 days, representing 0.048% of market capitalization
Risk Factors
- The total dollar amount, while meaningful, is still relatively small as a percentage of market cap (<0.05%)
- No accompanying fundamental update or news release to corroborate the timing of purchases
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-DCTH-1772832174967 |
Track record
12 reports on DCTH
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $21.38 Now $19.87 −7.06% settles Feb 10
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $20.27 Now $19.87 −1.97% settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $14.82 Now $19.87 +34.08% settles Feb 2
- Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $14.86 Now $19.87 +33.71% settles Jan 26
- Oct 19, 202628d ago SC 13D/A Neutral 4/10 Entry $14.37 Now $19.87 +38.27% settles Jan 14
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $11.77 to $16.48 Now $19.87 +68.89% ▲ +40.08% +35.68% vs SPY
- May 14, 202626w ago 8-K Neutral 3/10 Entry $11.46 to $16.67 Now $19.87 +73.39% ▲ +45.46% +41.87% vs SPY
- May 7, 202627w ago 8-K Neutral 5/10 Entry $11.24 to $13.04 Now $19.87 +76.78% ▲ +16.01% +12.18% vs SPY
- Apr 2, 202632w ago DEFA14A Neutral 3/10 Entry $9.63 to $12.59 Now $19.87 +106.33% ▲ +30.74% +16.58% vs SPY
- Mar 2, 202637w ago Insider Cluster Bullish 6/10 Viewing Entry $8.93 to $10.83 Now $19.87 +122.51% ▲ +21.28% +11.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers